Investments accounted for using the equity method (Details) - Hepalys Pharma, Inc |
12 Months Ended | ||||||||
|---|---|---|---|---|---|---|---|---|---|
|
Oct. 11, 2023
shares
|
Sep. 29, 2023 |
Sep. 26, 2023
¥ / shares
|
Sep. 26, 2023
€ / shares
|
Sep. 20, 2023
¥ / shares
|
Sep. 20, 2023
€ / shares
|
Dec. 31, 2025 |
Dec. 31, 2024 |
Dec. 31, 2023 |
|
| Investments accounted for using the equity method | |||||||||
| Group's share in % | 15.00% | 15.00% | 15.00% | 15.00% | |||||
| Hepalys Pharma, Inc | |||||||||
| Investments accounted for using the equity method | |||||||||
| Group's share in % | 15.00% | 15.00% | 15.00% | ||||||
| Catalys Option Agreement | |||||||||
| Investments accounted for using the equity method | |||||||||
| Option to acquire shares in company, percentage | 30.00% | 30.00% | 30.00% | 30.00% | |||||
| Number of shares acquired in associate | 1,500,000 | ||||||||
| Purchase of interests in investments accounted for using equity method, price per share | (per share) | ¥ 300 | € 1.9 | ¥ 300 | € 1.9 | |||||